Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin “resistance”

F Santilli, B Rocca, R De Cristofaro, S Lattanzio… - Journal of the American …, 2009 - jacc.org
Objective: This study was conducted to assess the thromboxane (TX) dependence of
biochemical and functional indexes used to monitor the effect of low-dose aspirin …

Residual arachidonic acid–induced platelet activation via an adenosine diphosphate–dependent but cyclooxygenase-1–and cyclooxygenase-2–independent …

AL Frelinger III, MI Furman, MD Linden, Y Li, ML Fox… - Circulation, 2006 - Am Heart Assoc
Background—Thrombotic events still occur in aspirin-treated patients with coronary artery
disease. Methods and Results—To better understand aspirin “resistance,” serum …

[HTML][HTML] Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway (s) in cardiovascular …

T Ohmori, Y Yatomi, T Nonaka, Y Kobayashi… - Journal of Thrombosis …, 2006 - Elsevier
Objectives: Although the concept of aspirin resistance is extensively reported in medical
literature, its precise mechanisms and clinical outcomes are largely unknown. In this study …

[HTML][HTML] Aspirin resistance: a revival of platelet aggregation tests?

G De Gaetano, C Cerletti - Journal of Thrombosis and Haemostasis, 2003 - jthjournal.org
Dear Sir, The concept of aspirin resistance was born together with the observation that
aspirin can interfere with factors of the hemostatic system [1]. Indeed as early as 1966, Quick …

Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population

N Faraday, DM Becker, LR Yanek… - The American journal of …, 2006 - Elsevier
Resistance to inhibition of platelet function by aspirin may contribute to future myocardial
infarction and stroke. Adverse cardiovascular outcomes have been associated with aspirin …

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

PA Gurbel, KP Bliden, J DiChiara, J Newcomer… - Circulation, 2007 - Am Heart Assoc
Background—The antiplatelet effect of aspirin is attributed to platelet cyclooxygenase-1
inhibition. Controversy exists on the prevalence of platelet resistance to aspirin in patients …

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

PA Gum, K Kottke-Marchant, ED Poggio, H Gurm… - The American journal of …, 2001 - Elsevier
We determined the prevalence and clinical predictors of aspirin resistance by prospectively
studying 325 patients with stable cardiovascular disease who were receiving aspirin (325 …

Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance

SA McKee, DC Sane… - Thrombosis and …, 2002 - thieme-connect.com
Salicylates have been used to treat pain and inflammation associated with rheumatism and
other conditions since ancient times. The Assyrians initially described the use of willow …

[HTML][HTML] Aspirin 'resistance': role of pre‐existent platelet reactivity and correlation between tests

AL Frelinger, Y Li, MD Linden, I Tarnow… - Journal of Thrombosis …, 2008 - Elsevier
Background: Aspirin 'resistance'is a widely used term for hyporesponsiveness to aspirin in a
platelet function test. Serum thromboxane (TX) B 2 is the most specific test of aspirin's effect …

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects

ML Capone, MG Sciulli, S Tacconelli, M Grana… - Journal of the American …, 2005 - jacc.org
Objectives: We investigated the occurrence of pharmacodynamic interaction between low-
dose aspirin and naproxen. Background: The uncertainty of cardioprotection by naproxen …